Ticker: ALLR

Snapshot - Allarity Therapeutics, Inc. (NASDAQ: ALLR) What's happening inside the company * Allarity is advancing its lead candidate stenoparib (Phase II expansion) and commercializing its DRP® companion-diagnostic technology - recent progress includes an IP Australia acceptance for the stenopari...